arrow
L

Lucian R. Chirieac

pathology
H指数:79
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to ‘Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact’ [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76]

《关于‘过去20年胸腺肿瘤学基础科学的进展及其转化影响’的勘误》[胸腺肿瘤学杂志 卷21 期1 (2026) 41-76]

2026-02-130
PRE
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact

过去20年胸外科肿瘤学基础科学的进展及其转化影响

2026-01-080
OA
Multi-omics, histologic, and scRNA-seq profiling of pleural mesothelioma reveals negative prognosis associated with a novel uncommitted molecular phenotype

多组学、组织病理学及单细胞RNA测序分析揭示,一种新型的未分化分子表型与恶性胸膜间皮瘤的不良预后相关。

2025-11-280
PRE
Non-Small Cell Lung Cancer, Version 4.2024

非小细胞肺癌4.2024版

2024-05-0150
PRE
Guideli nes for Pathologic Diagnosis of Mesothelioma 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group
2024-04-0810
OA
NCCN Continuing Education
2024-03-016
OA
Mesothelioma: Peritoneal, Version 2.2023
2023-09-019
OA
Non-Small Cell Lung Cancer, Version 3.2022
2022-05-01807
PRE
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis
2021-06-0131
PREAI
Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines

非小细胞肺癌,2.2021版以更新NCCN指南为特色

2021-03-01736
OA
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases
2021-02-0129
OAAI
Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel
2020-02-0138
OAAI
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines

非小细胞肺癌,1.2020版以更新NCCN指南为特色

2019-12-01567
OA